South Bend, IN, United States of America

Steve Marczak

This inventor holds 1 USPTO granted patent. Top assignee: University of Notre Dame Du Lac. Active years: 2020.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Steve Marczak: Innovator in Molecular Assays

Introduction

Steve Marczak is a notable inventor based in South Bend, Indiana. He has made significant contributions to the field of molecular diagnostics through his innovative work. His expertise lies in developing methods for detecting and quantifying biomolecules, which are crucial for various applications in biotechnology and medicine.

Latest Patents

Steve Marczak holds a patent for an "Ultra-sensitive multi-target lateral flow molecular assay with field-induced precipitation." This patent describes methods for detecting and quantifying biomolecules such as polynucleotides or polypeptides in an electrophoresis matrix using ion concentration polarization and nanoparticle aggregation. This innovative approach enhances the sensitivity and accuracy of molecular assays.

Career Highlights

Steve Marczak is affiliated with the University of Notre Dame. His work at this prestigious institution has allowed him to engage in cutting-edge research and contribute to advancements in molecular diagnostics. His dedication to innovation is evident in his patent and ongoing research efforts.

Collaborations

Steve collaborates with esteemed colleagues such as Hsueh-Chia Chang and Zdenek Slouka. These partnerships enhance the research environment and foster the development of new technologies in the field.

Conclusion

Steve Marczak is a prominent inventor whose work in molecular assays has the potential to impact various scientific fields. His innovative approaches and collaborations continue to drive advancements in biotechnology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…